Understanding the Market | MICROPORT rises over 6% again, accumulating more than 70% increase in the past seven days after Shanghai state-owned assets acquired shares and management increased their holdings

MicroPort Medical continues to rise over 6%, with a cumulative increase of over 70% in the past seven trading days. As of the time of writing, it is up 2.11%, priced at HKD 14.52, with a trading volume of HKD 266 million. In terms of news, on July 25th, MicroPort Medical's largest shareholder, Otsuka Medical Devices, sold 15.71% of its 20.70% stake to several buyers, including Shanghai Maitake 7.31% (Shanghai Shanshi Capital is the executive partner, with equity penetration from the Shanghai Finance Bureau, Shanghai State-owned Assets Supervision and Administration Commission, etc.), We'Tron Capital Limited 7.31%, and an investment platform under the management team of MicroPort 1.08%. Otsuka continues to hold about 5% of the shares. CICC pointed out that Shanshi Capital is an active fund management platform under the Shanghai State-owned Assets Supervision and Administration Commission, and this investment reflects the recognition of state-owned capital for MicroPort Group's assets, which is expected to help the company's core business expansion and potential strategic mergers and acquisitions, as well as improve the company's governance level. In addition, the original important shareholder We'Tron Capital Limited and the management team have both increased their holdings, which means that the interests of core shareholders and the management team are further deeply bound to the company